Dimed S.A. Distribuidora de Medicamentos Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, revenue was BRL 3,238.94 million compared to BRL 2,904.87 million a year ago. Net income was BRL 63.89 million compared to BRL 62.21 million a year ago. Basic earnings per share from continuing operations was BRL 0.43 compared to BRL 0.42 a year ago. Diluted earnings per share from continuing operations was BRL 0.43 compared to BRL 0.42 a year ago.